Sort   by:  
 Page size 
ProteomicsFyn- and Abl-driven interactome and post-translational modifications of DCBLD1 and DCBLD2
Three related datasets are included, all from immunoprecipitations of FLAG-tagged DCBLD1 and DCBLD2 (human) from 293 cells. Letters at the end of file names denote regions of each gel lave from highest (“A”) to lowest (“B”-X) molecular weight. File names containing “SILAC” are part of a dataset comp...
ORGANISM(S): Danio rerio (Zebrafish) (Brachydanio rerio) Homo sapiens (Human) 
2020-08-07 | PXD017723 | Pride
Clcp1 Dcbld2 Esdn Dcbld1 
GenomicsDCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
PRJNA707567 | ENA
GenomicsDCBLD2 promotes perivascular anti-tumor immune deprivation by educating SPP1+ pro-angiogenic macrophages
DCBLD2 promotes perivascular anti-tumor immune deprivation by educating SPP1+ pro-angiogenic macrophages
PRJNA1131102 | ENA
TranscriptomicsDCBLD2 promotes perivascular anti-tumor immune deprivation by educating SPP1+ pro-angiogenic macrophages
The crosstalk between tumor vasculature and immune microenvironment underpins the anti-tumor effect of anti-angiogenic therapy (AAT) combined with immunotherapy. However, the efficacy improved by AAT in the above combination therapy is limited and its adverse effects are concerning. Integrated trans...
ORGANISM(S): Homo sapiens 
2025-07-01 | GSE271377 | GEO
TranscriptomicsDCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
Growing evidence suggests that cisplatin and other chemotherapeutic agents promote tumor me-tastasis while inhibiting tumor growth, which is a critical issue in clinical practices. However, the role of chemotherapeutics in promoting tumor metastasis and the molecular mechanism involved are unclear. ...
ORGANISM(S): Homo sapiens 
2021-03-09 | GSE168498 | GEO
UnknownEGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis.
Not available
S-EPMC4151226 | biostudies-literature
UnknownPan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker.
Not available
S-EPMC9403722 | biostudies-literature
UnknownDCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma.
Not available
S-EPMC8003509 | biostudies-literature
UnknownTranscriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
Not available
S-EPMC8021715 | biostudies-literature
UnknownDCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance.
Not available
S-EPMC8170045 | biostudies-literature
Sort   by:  
 Page size